Intec Pharma Ltd. - Ordinary Shares (NTEC) Social Stream
Intec Pharma Ltd (NTEC) Price Targets From Analysts
Use the tables below to see what analysts covering Intec Pharma Ltd think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $13 | $13 | $13 | $9.05 | 43.65% |
Price Target Last Issued July 24, 2021
Over the past 14 months, NTEC's average upside potential has been 287.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-24 | 1 | 13.00 | 13.0 | 13.000 | 3.410 | 281.23% |
| 2021-07-17 | 1 | 13.00 | 13.0 | 13.000 | 3.370 | 285.76% |
| 2021-07-10 | 1 | 13.00 | 13.0 | 13.000 | 3.187 | 307.91% |
| 2021-07-03 | 1 | 13.00 | 13.0 | 13.000 | 3.490 | 272.49% |
| 2021-06-26 | 1 | 13.00 | 13.0 | 13.000 | 3.570 | 264.15% |
| 2021-06-13 | 1 | 13.00 | 13.0 | 13.000 | 3.880 | 235.05% |
| 2021-06-05 | 1 | 13.00 | 13.0 | 13.000 | 3.790 | 243.01% |
| 2021-05-22 | 1 | 13.00 | 13.0 | 13.000 | 3.810 | 241.21% |
| 2021-05-15 | 1 | 13.00 | 13.0 | 13.000 | 3.440 | 277.91% |
| 2021-05-08 | 1 | 13.00 | 13.0 | 13.000 | 3.540 | 267.23% |
| 2021-04-25 | 1 | 13.00 | 13.0 | 13.000 | 4.330 | 200.23% |
| 2021-04-17 | 1 | 13.00 | 13.0 | 13.000 | 3.830 | 239.43% |
| 2021-04-10 | 1 | 13.00 | 13.0 | 13.000 | 4.260 | 205.16% |
| 2021-04-03 | 1 | 13.00 | 13.0 | 13.000 | 4.530 | 186.98% |
| 2021-03-20 | 1 | 13.00 | 13.0 | 13.000 | 4.670 | 178.37% |
| 2021-03-13 | 2 | 13.00 | 5.0 | 9.000 | 4.590 | 96.08% |
| 2021-03-06 | 2 | 13.00 | 5.0 | 9.000 | 3.970 | 126.7% |
| 2021-02-27 | 2 | 13.00 | 5.0 | 9.000 | 4.390 | 105.01% |
| 2021-02-20 | 2 | 13.00 | 5.0 | 9.000 | 5.890 | 52.8% |
| 2021-02-13 | 2 | 13.00 | 5.0 | 9.000 | 6.100 | 47.54% |
| 2021-02-06 | 2 | 13.00 | 5.0 | 9.000 | 4.880 | 84.43% |
| 2021-01-30 | 2 | 13.00 | 5.0 | 9.000 | 4.080 | 120.59% |
| 2021-01-23 | 2 | 13.00 | 5.0 | 9.000 | 4.460 | 101.79% |
| 2021-01-16 | 2 | 13.00 | 5.0 | 9.000 | 4.130 | 117.92% |
| 2021-01-09 | 2 | 13.00 | 5.0 | 9.000 | 3.890 | 131.36% |
| 2021-01-02 | 2 | 13.00 | 5.0 | 9.000 | 3.450 | 160.87% |
| 2020-12-26 | 2 | 13.00 | 5.0 | 9.000 | 3.920 | 129.59% |
| 2020-12-19 | 2 | 13.00 | 5.0 | 9.000 | 3.930 | 129.01% |
| 2020-12-09 | 2 | 10.00 | 5.0 | 7.500 | 4.640 | 61.64% |
| 2020-12-07 | 2 | 10.00 | 5.0 | 7.500 | 3.400 | 120.59% |
| 2020-11-28 | 2 | 10.00 | 5.0 | 7.500 | 3.250 | 130.77% |
| 2020-10-19 | 1 | 10.00 | 10.0 | 10.000 | 0.241 | 4049.38% |
| 2020-08-05 | 1 | 0.50 | 0.5 | 0.500 | 0.413 | 21.07% |
| 2020-06-26 | 1 | 0.20 | 0.2 | 0.200 | NA | NA% |
| 2020-06-01 | 2 | 0.25 | 0.2 | 0.225 | NA | NA% |
NTEC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 1 | 0 | 2 | 0 | 0 | 3 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- NTEC has a greater number of analysts covering the stock than practically none of all US stocks.
- NTEC has a less variance in analysts' estimates than almost 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of NTEC is higher than 22.4% of Pharmaceutical Products stocks.
- NTEC has a greater average analyst price target than 24.72% of all US stocks.
Stocks similar to Intec Pharma Ltd in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEOG, CORT and EGRX.
Make investment decisions regarding NTEC using the data that counts. Try POWR Ratings for free.